Novo Nordisk is still playing catch up as Wegovy demand rockets upward
Wegovy demand continues to skyrocket and Novo Nordisk is still behind on meeting it, the company said as it unveiled soaring sales in the third …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
